About usSign in
Status
ACTIVE
Global HQ
London, United Kingdom
Countries of investment
  • United kingdom
Investment stages
  • Pre-Seed
  • Seed
Industries
  • AI
  • Transportationtech
  • Biotech
  • Enterprise
  • Cloud Infrastructure
  • Climatetech
  • Deeptech
About
2050 Capital is an earlystage venture capital firm specializing in deep tech and scientific investments. The firm applies a disciplined and surgical investment approach, backed by indepth due diligence. 2050 Capital typically invests $200500k in seed rounds and up to $3 M in followon investments, with a track record of over 50% in followon investments. The firm supports its portfolio companies with business development, strategy, and nextstage fundraising from the initial investment onward. Notable investments include companies such as AMFG, Blackrock Neurotech, ChAI, Hadean, KETS, Origin Sciences, Snyk, Vaticle, and OSCP.
Min check size
$200K
Max check size
$3M
Fund size
NPS

Investment Thesis

2050 Capital invests in transformative and defensible innovation that impacts large fundamental sectors, focusing on enterprise software (with a deep science component), computational biotech, and engineering and science ventures.
Lead investor
Co Invest
Number of exits
Preferred contact method

2050 Capital Contacts Information

Primary contact

Secondary contact

Team

Andreas Roelofs (Managing Partner)

Joshua Gilbert (Partner)

Portfolio

Origin

Blackrock Neurotech

KETS Quantum Security

One Silicon Chip Photonics

ChAI (Business/Productivity Software)

Hadean

Biofourmis

Paradromics

Neuroglee Health

Vaticle

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp